Open AccessA Randomized, Double-blind, Active-controlled Clinical Trial of a Cell Culture-derived Inactivated Trivalent Influenza Vaccine (NBP607) in Healthy Children 6 Months Through 18 Years of Age
Author(s) -
Chi Eun Oh,
Ui Yoon Choi,
Byung Wook Eun,
Taek Jin Lee,
Ki Hwan Kim,
Dong Ho Kim,
Nam Hee Kim,
Dae Sun Jo,
Sun Hee Shin,
Kyung Ho Kim,
Hun Kim,
Yun Kyung Kim
Publication year - 2018
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000001973
Subject(s) - immunogenicity , adverse effect , medicine , trivalent influenza vaccine , vaccination , influenza vaccine , clinical trial , live attenuated influenza vaccine , randomized controlled trial , immunology , influenzavirus b , influenza a virus , inactivated vaccine , antibody , virology , pediatrics , orthomyxoviridae , virus
Although a number of cell culture-derived influenza vaccines have been approved for use in adults, there have been few clinical trials of cell culture-derived seasonal influenza vaccines for young children.